نتایج جستجو برای: antituberculosis

تعداد نتایج: 1869  

Journal: :Circulation 2005
Bongani M Mayosi Lesley J Burgess Anton F Doubell

BACKGROUND The incidence of tuberculous pericarditis is increasing in Africa as a result of the human immunodeficiency virus (HIV) epidemic. The primary objective of this article was to review and summarize the literature on the pathogenesis, diagnosis, and management of tuberculous pericarditis. METHODS AND RESULTS We searched MEDLINE (January 1966 to May 2005) and the Cochrane Library (Issu...

Journal: :International journal of pharmaceutics & pharmacology 2021

The hepatoprotective properties of Alchornea cordifolia, a medicinal plant was studied in hepatotoxicity induced animal model with high dose paracetamol or carbon tetrachloride. Knowing that antituberculosis drugs also represent risk factor for hepatotoxicity, could A. cordifolia play key role to limit their hepatotoxicity? objective this study assess the histological changes rat livers and evo...

Journal: :Microbiology and Immunology 2021

Abstract Antituberculosis drug‐induced liver injury (ATDILI) has received increasing attention globally, which may limit the effectiveness of antituberculosis (anti‐TB) treatment. Many host genetic determinants ATDILI have been identified recently. As little knowledge is currently available about association between aldehyde dehydrogenase 1 family member A1 (ALDH1A1) polymorphisms and ATDILI, t...

Journal: :BMC Infectious Diseases 2004
Chiranjoy Mukhopadhyay Ankita Garg Archana Ayyagari

BACKGROUND MDR Mycobacterium tuberculosis is the major cause of treatment failure in tuberculosis patients, especially in immunosuppressed. We described a young polymyositis patient on immunosuppressive therapy who was started with antituberculosis therapy as a susceptible strain of M. tuberculosis was isolated from a single cutaneous abscess in his neck and from regional lymph nodes. CASE PR...

Journal: :Medecine et sante tropicales 2012
Y Maiga Y Toloba P M'belesso R Danièle Y Cissoko S Illiassou M Y Maiga H A Traoré

BACKGROUND The incidence of tuberculosis is high in Africa. It is treated with medications that can trigger neuropathic pain and thus negatively affect patients' quality of life and treatment compliance. The aim of this study was to investigate neuropathic pain due to antituberculosis drugs in patients without HIV infection. METHODS This prospective study, conducted in the pulmonology departm...

Journal: :Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2012
A Zaoui A Abdelghani H Ben Salem W Ouanes A Hayouni F Khachnaoui N Rejeb M Benzarti

Nervous system toxicity with current antituberculosis pharmacotherapy is relatively uncommon, although the frequency of the usage of antituberculosis therapy requires that physicians should be aware of such toxicity. Peripheral neuropathy is a rare adverse effect associated with isoniazid, and it occurs after the prolonged use of this drug [1]. This usually presents with paresthesias which can ...

Journal: :Roczniki Akademii Medycznej w Bialymstoku 2004
A Dubaniewicz A Hoppe

PURPOSE The aim of this study was to evaluate the ability of the NBT reduction by non- and BCG-stimulated monocytes isolated from peripheral blood persons with pulmonary tuberculosis (TB) before treatment, after two-month antituberculosis therapy and in an inactive stage of this disease. MATERIAL AND METHODS The spontaneous and induced NBT tests were done in 24 healthy individuals and 59 pati...

Journal: :Pediatrics 1999
M L Sierra E Vegas J E Blanco-González GonzálezA P Martínez M A Calero

Kikuchi's disease (KD), or histiocytic necrotizing lymphadenitis, was initially described in Japan in 1972. In the following years, several series of cases involving patients of different ages, races, and geographic origins were reported, but pediatric reports have been rare. The etiology of KD is unknown, although a viral or autoimmune hypothesis has been suggested. The most frequent clinical ...

Journal: :Lancet 2010
Zhenkun Ma Christian Lienhardt Helen McIlleron Andrew J Nunn Xiexiu Wang

Drugs for tuberculosis are inadequate to address the many inherent and emerging challenges of treatment. In the past decade, ten compounds have progressed into the clinical development pipeline, including six new compounds specifically developed for tuberculosis. Despite this progress, the global drug pipeline for tuberculosis is still insufficient to address the unmet needs of treatment. Addit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید